Conditions: Overactive Bladder
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 153
Healthy volunteers: no

Brief summary:
To assess the long term safety, tolerability and efficacy of fesoterodine in patients with OAB.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: fesoterodine fumarate
Intervention descriptions: intervention 1: 4 mg tablets OD for 4 weeks, then either 4 mg or 8 mg tablets OD for 48 weeks

Protocol document: